Monte Rosa Therapeutics, Inc. (GLUE)

NASDAQ: GLUE · Real-Time Price · USD

10.04

+1.58 (18.68%)

At close: Oct 10, 2025, 4:00 PM EDT

9.82

-0.22 (-2.19%)

After-hours: Oct 10, 2025, 7:59 PM EDT

Monte Rosa Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	177.99	75.62	-	-	-	-
Gross Profit	177.99	75.62	-	-	-	-
Selling, General & Admin	33.7	35.17	32.04	27.32	15.73	4.01
Research & Development	129.33	121.56	111.27	85.06	57.16	24.01
Total Operating Expenses	163.03	156.73	143.31	112.38	72.88	28.01
Operating Income	14.96	-81.11	-143.31	-112.38	-72.88	-28.01
Interest Income	11.99	10.57	9.33	3.76	0.05	0.01
Other Non-Operating Income (Expense)	1.41	0.42	-1.04	0.12	-1.12	-7.88
Total Non-Operating Income (Expense)	13.41	10.98	8.3	3.88	-1.08	-7.87
Pretax Income	28.37	-70.13	-135.01	-108.5	-73.96	-35.88
Provision for Income Taxes	-4.26	-2.57	-0.34	-	-	-
Net Income	24.17	-72.7	-135.35	-108.5	-73.96	-35.88
Net Income to Common	24.17	-72.7	-135.35	-108.5	-73.96	-35.88
Shares Outstanding (Basic)	82	74	51	47	25	2
Shares Outstanding (Diluted)	82	74	51	47	25	2
Shares Change (YoY)	38.24%	43.80%	8.83%	88.91%	1548.09%	-
EPS (Basic)	0.36	-0.98	-2.63	-2.30	-2.96	-23.65
EPS (Diluted)	0.36	-0.98	-2.63	-2.30	-2.96	-23.65
Free Cash Flow	23.85	38.01	-62.84	-105.38	-69.1	-26.44
Free Cash Flow Growth	-37.24%	-	-	-	-	-
Free Cash Flow Per Share	0.29	0.51	-1.22	-2.23	-2.76	-17.43
Gross Margin	100.00%	100.00%	-	-	-	-
Operating Margin	8.40%	-107.26%	-	-	-	-
Profit Margin	18.33%	-89.34%	-	-	-	-
FCF Margin	13.40%	50.26%	-	-	-	-
EBITDA	23.3	-72.99	-137.09	-108.64	-70.75	-27.47
EBITDA Margin	13.09%	-96.52%	-	-	-	-
EBIT	14.96	-81.11	-143.31	-112.38	-72.88	-28.01
EBIT Margin	8.40%	-107.26%	-	-	-	-
Effective Tax Rate	-15.00%	3.66%	0.25%	0.00%	0.00%	0.00%

Updated Aug 7, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q